Andere Sprachen Aiforia Technologies Oyj

Aktien

A3C88G

FI4000507934

AIFORIA

Markt geschlossen - Nasdaq Helsinki Andere Börsenplätze 17:23:08 29.04.2024			% 5 Tage	% 1. Jan.
3,91 ^EUR	-1,51 %		+6,83 %	+12,03 %

09.04.	Aiforia Technologies Oyj beruft Richard Haworth in seinen wissenschaftlichen Beirat	CI
07.03.	Aiforia Technologies Oyj meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Aiforia Technologies Oyj Appoints Richard Haworth to Its Scientific Advisory Board	09.04.
Aiforia Technologies Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	07.03.
Aiforia Technologies Plc Releases Aiforia Studies A Software Module Offerering Ai-Assisted Image Analysis Workflow	06.03.
Aiforia Technologies Plc updates its short and mid-term business targets	19.01.
Aiforia Partners with US Nonprofit to Commercialize AI Predicting Colorectal Cancer Recurrence	02.01.
Aiforia signs a licensing agreement with the Mayo Clinic for an AI model that improves prediction of colorectal cancer recurrence	02.01.
Aiforia Signs a Licensing Agreement with the Mayo Clinic for an AI Model That Improves Prediction of Colorectal Cancer Recurrence	02.01.
Aiforia Technologies Enters Three-year Technology Deal with Italian Hospital	27.12.
Aiforia Signs A Deal with an Italian Hospital in Catania	27.12.
Aiforia signs a deal with an Italian hospital in Catania	27.12.
Share subscriptions based on stock options 2016A	22.12.
Aiforia Technologies Plc - Managers' Transactions	19.12.
Professor Inti Zlobec joins Aiforia's Scientific Advisory Board	08.12.
Aiforia Technologies Oyj Announces Appointment of Professor Inti Zlobec to Its Scientific Advisory Board	08.12.
Aiforia Technologies Plc's financial reporting and Annual General Meeting in financial year 2024	04.12.
Change in Aiforia Technologies Plc's Management Team	01.12.
Aiforia Technologies plc Appoints Panu Kauppila as Chief Product Officer and A Member of the Management Team	01.12.
Aiforia's transition to IFRS reporting	01.12.
Aiforia initiates path to secure its first regulatory approval in the United States - application to the FDA anticipated in 2024	20.10.23
Aiforia Technologies Plc Initiates Path to Secure its First Regulatory Approval in the United States	20.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Aiforia Technologies Oyj

Aktien

A3C88G

FI4000507934

AIFORIA

Andere Sprachen

Filter